Liberty Capital Management’s Gilead Sciences GILD Stock Holding History

Liberty Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,360	Closed	-$107K	–	150
2017 Q4	$107K	Sell	1,360 -1,180	-46%	-$89.6K	0.06%	139
2017 Q3	$206K	Hold	2,540	–	–	0.11%	116
2017 Q2	$176K	Sell	2,540 -765	-23%	-$50.9K	0.11%	116
2017 Q1	$224K	Hold	3,305	–	–	0.13%	105
2016 Q4	$238K	Hold	3,305	–	–	0.15%	99
2016 Q3	$255K	Sell	3,305 -3,605	-52%	-$293K	0.17%	99
2016 Q2	$576K	Buy	6,910 +1,830	+36%	+$162K	0.39%	67
2016 Q1	$467K	Buy	5,080 +575	+13%	+$51.9K	0.35%	67
2015 Q4	$456K	Sell	4,505 -240	-5%	-$25K	0.34%	68
2015 Q3	$466K	Sell	4,745 -1,485	-24%	-$165K	0.37%	71
2015 Q2	$729K	Buy	6,230 +370	+6%	+$40.4K	0.49%	64
2015 Q1	$575K	Buy	5,860 +3,705	+172%	+$376K	0.38%	73
2014 Q4	$203K	Buy	+2,155	New	+$223K	0.14%	99

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Liberty Capital Management's GILD Position: Q1 2018 in Review

Liberty Capital Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 1,360 shares — an estimated $107K sold.

Liberty Capital Management first reported a position in GILD in Q4 2014 and held it in 13 quarters. The position peaked at $729K in Q2 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

Liberty Capital Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
Liberty Capital Management sold 1,360 Gilead Sciences shares in Q1 2018, an estimated $107K.
Liberty Capital Management first reported a position in Gilead Sciences in Q4 2014 and held it in 13 quarters.
Liberty Capital Management's Gilead Sciences position peaked at $729K in Q2 2015.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Liberty Capital Management's 13F filing for Q1 2018, filed 25 Apr 2018.